US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 20.760
  • +0.740+3.70%
Close Apr 26 16:00 ET
  • 20.800
  • +0.040+0.19%
Post 18:11 ET
2.00BMarket Cap-3830P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-23.51%912.22M
-23.51%912.22M
3.21%854.79M
3.87%908.07M
9.15%933.54M
59.29%1.19B
59.29%1.19B
3.75%828.19M
65.26%874.28M
46.43%855.25M
-Cash and cash equivalents
-56.69%226.75M
-56.69%226.75M
19.00%168.03M
16.26%171.81M
120.53%294.15M
324.21%523.51M
324.21%523.51M
-57.82%141.19M
13.78%147.78M
-5.76%133.38M
-Short-term investments
2.44%685.48M
2.44%685.48M
-0.03%686.76M
1.35%736.27M
-11.43%639.39M
7.01%669.12M
7.01%669.12M
48.21%687M
82.01%726.49M
63.13%721.87M
Receivables
867.52%36.46M
867.52%36.46M
61.35%6.49M
77.15%5.06M
172.40%4.91M
85.52%3.77M
85.52%3.77M
61.50%4.02M
43.20%2.85M
88.98%1.8M
-Accounts receivable
867.52%36.46M
867.52%36.46M
61.35%6.49M
77.15%5.06M
172.40%4.91M
85.52%3.77M
85.52%3.77M
61.50%4.02M
43.20%2.85M
88.98%1.8M
Other current assets
143.30%49.65M
143.30%49.65M
20.52%32.21M
44.70%26.49M
37.72%25.22M
9.81%20.41M
9.81%20.41M
90.71%26.73M
-0.48%18.3M
13.98%18.32M
Total current assets
-17.95%998.33M
-17.95%998.33M
4.02%893.49M
4.93%939.62M
10.09%963.67M
58.17%1.22B
58.17%1.22B
5.42%858.95M
62.98%895.43M
45.63%875.37M
Non current assets
Net PPE
-7.99%148.14M
-7.99%148.14M
19.30%152.58M
57.31%156.74M
59.60%159.87M
60.82%161M
60.82%161M
25.71%127.89M
4.23%99.64M
6.49%100.17M
-Gross PPE
-3.19%188M
-3.19%188M
19.30%152.58M
57.31%156.74M
59.60%159.87M
53.85%194.2M
53.85%194.2M
25.71%127.89M
4.23%99.64M
6.49%100.17M
-Accumulated depreciation
-20.07%-39.86M
-20.07%-39.86M
----
----
----
-27.13%-33.2M
-27.13%-33.2M
----
----
----
Investments and advances
8.57%154.51M
8.57%154.51M
102.08%197.28M
96.69%226.88M
29.53%294.35M
-66.52%142.32M
-66.52%142.32M
-76.38%97.62M
418.14%115.35M
1,257.94%227.25M
Total non current assets
-0.22%302.65M
-0.22%302.65M
55.14%349.86M
78.44%383.63M
38.73%454.22M
-42.24%303.32M
-42.24%303.32M
-56.65%225.51M
75.02%214.99M
182.73%327.42M
Total assets
-14.42%1.3B
-14.42%1.3B
14.65%1.24B
19.17%1.32B
17.88%1.42B
17.43%1.52B
17.43%1.52B
-18.76%1.08B
65.18%1.11B
67.78%1.2B
Liabilities
Current liabilities
Payables
44.59%7.45M
44.59%7.45M
-18.96%3.55M
54.81%11.63M
-32.04%6.89M
-46.61%5.15M
-46.61%5.15M
-41.31%4.38M
9.64%7.52M
16.69%10.14M
-accounts payable
44.59%7.45M
44.59%7.45M
-18.96%3.55M
54.81%11.63M
-32.04%6.89M
-46.61%5.15M
-46.61%5.15M
-41.31%4.38M
9.64%7.52M
16.69%10.14M
Current accrued expenses
3.34%40.4M
3.34%40.4M
-8.61%36.97M
5.72%33.82M
9.57%34.76M
70.36%39.1M
70.36%39.1M
215.94%40.46M
18.00%31.99M
111.92%31.73M
Current debt and capital lease obligation
11.47%18.6M
11.47%18.6M
26.00%17.07M
75.06%16.75M
74.86%16.33M
83.11%16.69M
83.11%16.69M
55.67%13.55M
29.04%9.57M
13.12%9.34M
-Current capital lease obligation
11.47%18.6M
11.47%18.6M
26.00%17.07M
75.06%16.75M
74.86%16.33M
83.11%16.69M
83.11%16.69M
55.67%13.55M
29.04%9.57M
13.12%9.34M
Current deferred liabilities
-49.50%22.14M
-49.50%22.14M
-75.65%13.35M
-64.51%21.93M
-44.57%35.34M
-31.24%43.84M
-31.24%43.84M
-3.42%54.82M
174.16%61.81M
182.82%63.76M
Current liabilities
-8.97%115.21M
-8.97%115.21M
-29.88%91.95M
-19.32%99.85M
-18.02%103.38M
0.57%126.55M
0.57%126.55M
34.40%131.13M
67.33%123.76M
107.75%126.11M
Non current liabilities
Long term debt and capital lease obligation
-15.15%96.75M
-15.15%96.75M
20.41%101.26M
75.98%105.58M
75.74%109.8M
75.65%114.02M
75.65%114.02M
25.01%84.1M
-5.16%60M
-3.11%62.48M
-Long term capital lease obligation
-15.15%96.75M
-15.15%96.75M
20.41%101.26M
75.98%105.58M
75.74%109.8M
75.65%114.02M
75.65%114.02M
25.01%84.1M
-5.16%60M
-3.11%62.48M
Non current deferred liabilities
94.93%38.85M
94.93%38.85M
-50.47%12.72M
-63.43%12.92M
-71.99%13.86M
-68.60%19.93M
-68.60%19.93M
-59.26%25.68M
-12.13%35.33M
7.97%49.48M
Other non current liabilities
----
----
----
----
----
--24.03M
--24.03M
--18.6M
--10.79M
--10.96M
Total non current liabilities
-14.16%135.6M
-14.16%135.6M
-11.21%113.98M
11.67%118.5M
0.60%123.66M
23.05%157.98M
23.05%157.98M
-1.47%128.38M
2.56%106.12M
11.43%122.92M
Total liabilities
-11.85%250.81M
-11.85%250.81M
-20.64%205.94M
-5.01%218.35M
-8.83%227.05M
11.92%284.53M
11.92%284.53M
13.89%259.51M
29.56%229.88M
45.62%249.03M
Shareholders'equity
Share capital
0.00%9K
0.00%9K
12.50%9K
12.50%9K
12.50%9K
28.57%9K
28.57%9K
14.29%8K
14.29%8K
14.29%8K
-common stock
0.00%9K
0.00%9K
12.50%9K
12.50%9K
12.50%9K
28.57%9K
28.57%9K
14.29%8K
14.29%8K
14.29%8K
Retained earnings
-40.88%-1.66B
-40.88%-1.66B
-43.47%-1.53B
-47.70%-1.4B
-50.65%-1.28B
-67.45%-1.18B
-67.45%-1.18B
-71.09%-1.06B
-72.79%-950.55M
-76.57%-849.87M
Paid-in capital
12.01%2.71B
12.01%2.71B
35.25%2.57B
36.51%2.51B
36.55%2.47B
38.63%2.42B
38.63%2.42B
9.78%1.9B
76.15%1.84B
76.37%1.81B
Gains losses not affecting retained earnings
69.74%-2.26M
69.74%-2.26M
61.87%-3.57M
59.51%-3.87M
66.78%-2.68M
-183.47%-7.46M
-183.47%-7.46M
-5,283.91%-9.37M
-73,392.31%-9.55M
-67,083.33%-8.06M
Total stockholders'equity
-15.01%1.05B
-15.01%1.05B
25.75%1.04B
25.48%1.1B
24.86%1.19B
18.78%1.24B
18.78%1.24B
-25.49%824.95M
77.96%880.55M
74.72%953.75M
Total equity
-15.01%1.05B
-15.01%1.05B
25.75%1.04B
25.48%1.1B
24.86%1.19B
18.78%1.24B
18.78%1.24B
-25.49%824.95M
77.96%880.55M
74.72%953.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -23.51%912.22M-23.51%912.22M3.21%854.79M3.87%908.07M9.15%933.54M59.29%1.19B59.29%1.19B3.75%828.19M65.26%874.28M46.43%855.25M
-Cash and cash equivalents -56.69%226.75M-56.69%226.75M19.00%168.03M16.26%171.81M120.53%294.15M324.21%523.51M324.21%523.51M-57.82%141.19M13.78%147.78M-5.76%133.38M
-Short-term investments 2.44%685.48M2.44%685.48M-0.03%686.76M1.35%736.27M-11.43%639.39M7.01%669.12M7.01%669.12M48.21%687M82.01%726.49M63.13%721.87M
Receivables 867.52%36.46M867.52%36.46M61.35%6.49M77.15%5.06M172.40%4.91M85.52%3.77M85.52%3.77M61.50%4.02M43.20%2.85M88.98%1.8M
-Accounts receivable 867.52%36.46M867.52%36.46M61.35%6.49M77.15%5.06M172.40%4.91M85.52%3.77M85.52%3.77M61.50%4.02M43.20%2.85M88.98%1.8M
Other current assets 143.30%49.65M143.30%49.65M20.52%32.21M44.70%26.49M37.72%25.22M9.81%20.41M9.81%20.41M90.71%26.73M-0.48%18.3M13.98%18.32M
Total current assets -17.95%998.33M-17.95%998.33M4.02%893.49M4.93%939.62M10.09%963.67M58.17%1.22B58.17%1.22B5.42%858.95M62.98%895.43M45.63%875.37M
Non current assets
Net PPE -7.99%148.14M-7.99%148.14M19.30%152.58M57.31%156.74M59.60%159.87M60.82%161M60.82%161M25.71%127.89M4.23%99.64M6.49%100.17M
-Gross PPE -3.19%188M-3.19%188M19.30%152.58M57.31%156.74M59.60%159.87M53.85%194.2M53.85%194.2M25.71%127.89M4.23%99.64M6.49%100.17M
-Accumulated depreciation -20.07%-39.86M-20.07%-39.86M-------------27.13%-33.2M-27.13%-33.2M------------
Investments and advances 8.57%154.51M8.57%154.51M102.08%197.28M96.69%226.88M29.53%294.35M-66.52%142.32M-66.52%142.32M-76.38%97.62M418.14%115.35M1,257.94%227.25M
Total non current assets -0.22%302.65M-0.22%302.65M55.14%349.86M78.44%383.63M38.73%454.22M-42.24%303.32M-42.24%303.32M-56.65%225.51M75.02%214.99M182.73%327.42M
Total assets -14.42%1.3B-14.42%1.3B14.65%1.24B19.17%1.32B17.88%1.42B17.43%1.52B17.43%1.52B-18.76%1.08B65.18%1.11B67.78%1.2B
Liabilities
Current liabilities
Payables 44.59%7.45M44.59%7.45M-18.96%3.55M54.81%11.63M-32.04%6.89M-46.61%5.15M-46.61%5.15M-41.31%4.38M9.64%7.52M16.69%10.14M
-accounts payable 44.59%7.45M44.59%7.45M-18.96%3.55M54.81%11.63M-32.04%6.89M-46.61%5.15M-46.61%5.15M-41.31%4.38M9.64%7.52M16.69%10.14M
Current accrued expenses 3.34%40.4M3.34%40.4M-8.61%36.97M5.72%33.82M9.57%34.76M70.36%39.1M70.36%39.1M215.94%40.46M18.00%31.99M111.92%31.73M
Current debt and capital lease obligation 11.47%18.6M11.47%18.6M26.00%17.07M75.06%16.75M74.86%16.33M83.11%16.69M83.11%16.69M55.67%13.55M29.04%9.57M13.12%9.34M
-Current capital lease obligation 11.47%18.6M11.47%18.6M26.00%17.07M75.06%16.75M74.86%16.33M83.11%16.69M83.11%16.69M55.67%13.55M29.04%9.57M13.12%9.34M
Current deferred liabilities -49.50%22.14M-49.50%22.14M-75.65%13.35M-64.51%21.93M-44.57%35.34M-31.24%43.84M-31.24%43.84M-3.42%54.82M174.16%61.81M182.82%63.76M
Current liabilities -8.97%115.21M-8.97%115.21M-29.88%91.95M-19.32%99.85M-18.02%103.38M0.57%126.55M0.57%126.55M34.40%131.13M67.33%123.76M107.75%126.11M
Non current liabilities
Long term debt and capital lease obligation -15.15%96.75M-15.15%96.75M20.41%101.26M75.98%105.58M75.74%109.8M75.65%114.02M75.65%114.02M25.01%84.1M-5.16%60M-3.11%62.48M
-Long term capital lease obligation -15.15%96.75M-15.15%96.75M20.41%101.26M75.98%105.58M75.74%109.8M75.65%114.02M75.65%114.02M25.01%84.1M-5.16%60M-3.11%62.48M
Non current deferred liabilities 94.93%38.85M94.93%38.85M-50.47%12.72M-63.43%12.92M-71.99%13.86M-68.60%19.93M-68.60%19.93M-59.26%25.68M-12.13%35.33M7.97%49.48M
Other non current liabilities ----------------------24.03M--24.03M--18.6M--10.79M--10.96M
Total non current liabilities -14.16%135.6M-14.16%135.6M-11.21%113.98M11.67%118.5M0.60%123.66M23.05%157.98M23.05%157.98M-1.47%128.38M2.56%106.12M11.43%122.92M
Total liabilities -11.85%250.81M-11.85%250.81M-20.64%205.94M-5.01%218.35M-8.83%227.05M11.92%284.53M11.92%284.53M13.89%259.51M29.56%229.88M45.62%249.03M
Shareholders'equity
Share capital 0.00%9K0.00%9K12.50%9K12.50%9K12.50%9K28.57%9K28.57%9K14.29%8K14.29%8K14.29%8K
-common stock 0.00%9K0.00%9K12.50%9K12.50%9K12.50%9K28.57%9K28.57%9K14.29%8K14.29%8K14.29%8K
Retained earnings -40.88%-1.66B-40.88%-1.66B-43.47%-1.53B-47.70%-1.4B-50.65%-1.28B-67.45%-1.18B-67.45%-1.18B-71.09%-1.06B-72.79%-950.55M-76.57%-849.87M
Paid-in capital 12.01%2.71B12.01%2.71B35.25%2.57B36.51%2.51B36.55%2.47B38.63%2.42B38.63%2.42B9.78%1.9B76.15%1.84B76.37%1.81B
Gains losses not affecting retained earnings 69.74%-2.26M69.74%-2.26M61.87%-3.57M59.51%-3.87M66.78%-2.68M-183.47%-7.46M-183.47%-7.46M-5,283.91%-9.37M-73,392.31%-9.55M-67,083.33%-8.06M
Total stockholders'equity -15.01%1.05B-15.01%1.05B25.75%1.04B25.48%1.1B24.86%1.19B18.78%1.24B18.78%1.24B-25.49%824.95M77.96%880.55M74.72%953.75M
Total equity -15.01%1.05B-15.01%1.05B25.75%1.04B25.48%1.1B24.86%1.19B18.78%1.24B18.78%1.24B-25.49%824.95M77.96%880.55M74.72%953.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%
ARK Holdings
ARK Holdings
Intraday+0.05%